CD11B+ peripheral cells were mostly identified in studies concerned with inflammatory bone loss, including TNF-α-driven bone loss or within models of experimentally induced rheumatoid arthritis [74,76,78,79]. This evidence concerns the gene TNF and rheumatoid arthritis.